Anti-melanogenic effects of resorcinol are mediated by suppression of cAMP signaling and activation of p38 MAPK signaling
- Authors
- Kang, Mingyeong; Park, See-Hyoung; Oh, Sae Woong; Lee, Seung Eun; Yoo, Ju Ah; Nho, Youn Hwa; Lee, Sukyeon; Han, Byung Seok; Cho, Jae Youl; Lee, Jongsung
- Issue Date
- 2018
- Publisher
- TAYLOR & FRANCIS LTD
- Keywords
- Resorcinol; melanogenesis; cAMP; p38 MAPK
- Citation
- BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, v.82, no.7, pp.1188 - 1196
- Journal Title
- BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Volume
- 82
- Number
- 7
- Start Page
- 1188
- End Page
- 1196
- URI
- https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/4791
- DOI
- 10.1080/09168451.2018.1459176
- ISSN
- 0916-8451
- Abstract
- In this study, we investigated the inhibitory mechanisms of resorcinol in B16F10 mouse melanoma cells. We found that resorcinol reduced both the melanin content and tyrosinase activity in these cells. In addition, resorcinol suppressed the expression of melanogenic gene microphthalmia-associated transcriptional factor (MITF) and its downstream target genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2. In addition, we found that resorcinol reduced intracellular cAMP levels and protein kinase A (PKA) activity, and increased phosphorylation of the p38 mitogen-activated protein kinase (MAPK). Resorcinol was also found to directly inhibit tyrosinase activity. However, resorcinol-induced decrease in melanin content, tyrosinase activity, and tyrosinase protein levels were attenuated by SB203580, a p38 MAPK inhibitor. Taken together, these data indicate that anti-melanogenic activity of resorcinol is be mediated through the inhibition of cAMP signaling and activation of p38 MAPK, indicating that resorcinol may be a possible ameliorating agent in the treatment of hyperpigmentation skin disorders.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Science and Technology > Department of Biological and Chemical Engineering > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.